ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $61,061 | -54.8% | 93,594 | -24.4% | 0.00% | – |
Q4 2021 | $135,000 | -41.8% | 123,777 | -2.9% | 0.00% | – |
Q3 2021 | $232,000 | -28.2% | 127,449 | +4.2% | 0.00% | – |
Q2 2021 | $323,000 | -26.3% | 122,343 | +0.6% | 0.00% | – |
Q1 2021 | $438,000 | +31.9% | 121,634 | -7.7% | 0.00% | – |
Q4 2020 | $332,000 | +3.1% | 131,743 | +3.1% | 0.00% | – |
Q3 2020 | $322,000 | -21.5% | 127,752 | 0.0% | 0.00% | – |
Q2 2020 | $410,000 | +48.6% | 127,752 | +13.6% | 0.00% | – |
Q1 2020 | $276,000 | -39.7% | 112,470 | +16.0% | 0.00% | – |
Q4 2019 | $458,000 | +8.3% | 96,954 | -3.4% | 0.00% | – |
Q3 2019 | $423,000 | -27.8% | 100,320 | -0.2% | 0.00% | -100.0% |
Q2 2019 | $586,000 | +70.3% | 100,536 | +12.7% | 0.00% | – |
Q1 2019 | $344,000 | +91.1% | 89,180 | -7.1% | 0.00% | – |
Q4 2018 | $180,000 | -38.6% | 95,994 | +5.0% | 0.00% | – |
Q3 2018 | $293,000 | -7.6% | 91,454 | -12.7% | 0.00% | – |
Q2 2018 | $317,000 | -20.2% | 104,728 | +3.4% | 0.00% | – |
Q1 2018 | $397,000 | -6.8% | 101,328 | -1.6% | 0.00% | – |
Q4 2017 | $426,000 | -32.4% | 102,937 | +0.3% | 0.00% | -100.0% |
Q3 2017 | $630,000 | -2.9% | 102,581 | -1.8% | 0.00% | 0.0% |
Q2 2017 | $649,000 | +5.9% | 104,447 | +8.2% | 0.00% | 0.0% |
Q1 2017 | $613,000 | +35.3% | 96,501 | +14.0% | 0.00% | 0.0% |
Q4 2016 | $453,000 | -4.6% | 84,676 | +0.4% | 0.00% | 0.0% |
Q3 2016 | $475,000 | +3.0% | 84,332 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $461,000 | -17.4% | 84,137 | +9.3% | 0.00% | – |
Q1 2016 | $558,000 | -11.8% | 76,961 | +1.0% | 0.00% | -100.0% |
Q4 2015 | $633,000 | -6.9% | 76,181 | +0.9% | 0.00% | 0.0% |
Q3 2015 | $680,000 | -23.0% | 75,476 | +2.6% | 0.00% | 0.0% |
Q2 2015 | $883,000 | +42.4% | 73,545 | +27.8% | 0.00% | 0.0% |
Q1 2015 | $620,000 | +124.6% | 57,564 | +6.0% | 0.00% | – |
Q4 2014 | $276,000 | +87.8% | 54,296 | -2.4% | 0.00% | – |
Q3 2014 | $147,000 | -32.9% | 55,656 | +2.3% | 0.00% | – |
Q2 2014 | $219,000 | -24.0% | 54,384 | -13.4% | 0.00% | – |
Q1 2014 | $288,000 | +23.6% | 62,825 | +17.4% | 0.00% | – |
Q4 2013 | $233,000 | +11.5% | 53,509 | +0.9% | 0.00% | – |
Q3 2013 | $209,000 | +81.7% | 53,050 | -2.9% | 0.00% | – |
Q2 2013 | $115,000 | – | 54,642 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |